MicroCC-25 Plus

The MicroCC-25 Plus Advanced Hematology Analyzer is a fully automated, 5-part differential (5-diff) benchtop hematology analyzer designed for small to medium-volume clinical laboratories, hospital satellite labs, and physician office laboratories . The instrument measures 25 parameters including complete blood count (CBC) with WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW-CV, RDW-SD, PLT, MPV, PDW, PCT, P-LCR, P-LCC , and a five-part white blood cell differential (NEU, LYM, MON, EOS, BAS) with both absolute counts and percentages . It also reports 4 research parameters including atypical lymphocytes (ALY#, ALY%) and immature granulocytes (IG#, IG%) .

Operating at 60 samples per hour with sample volumes of just 15 µL for whole blood or 20 µL for pre-diluted capillary samples , the analyzer uses laser flow cytometry for the 5-part differential, electrical impedance (80 µm ruby aperture) for RBC and platelet counting, and colorimetric photometry (550 nm) for hemoglobin measurement . The 10.4 inch color LCD touchscreen with Windows-based operating system provides an intuitive graphical user interface with language options including English, Spanish, Russian, French, and Ukrainian .

The analyzer features comprehensive quality control with built-in L‑J, X‑R, and X‑B charting, 60 QC files x 500 results, mean/SD/CV% calculation, 100,000 patient result memory with complete histograms and demographics, reagent level monitoring with RFID tag identification, and bi-directional LIS connectivity (HL7 compatible) via USB x4, RJ-45 Ethernet, and external barcode reader . The built-in thermal printer and external printer support provide flexible result output options .

For the clinical laboratory scientist and pathologist, the MicroCC‑25 Plus provides reliable, cost-effective hematology testing that supports accurate diagnosis of anemia, infection, inflammation, thrombocytopenia, and hematologic malignancies across all patient populations including pediatric and geriatric patients requiring minimal specimen volumes . For the patient, rapid (60 tests/hour) and accurate CBC plus 5-part differential results enable timely diagnosis of anemia, early detection of infection, monitoring of chemotherapy effects, preoperative risk assessment, and appropriate treatment for bleeding disorders and hematologic diseases .